Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer

MicroRNA-106b-25 cluster targets β-TRCP2, increases the expression of Snail and enhances cell migration and invasion in H1299 (non small cell lung cancer) cells

(2013) Udainiya Savita et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

CEA, SCC and NSE levels in exhaled breath condensate—possible markers for early detection of lung cancer

(2013) Yingchang Zou et al.   Journal of Breath Research

MiR-93 enhances angiogenesis and metastasis by targeting LATS2

(2012) Ling Fang et al.   CELL CYCLE

Circulating microRNAs in plasma as early detection markers for breast cancer

(2012) Katarina Cuk et al.   INTERNATIONAL JOURNAL OF CANCER

Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients

(2012) Han-Bo Le et al.   MEDICAL ONCOLOGY

A panel of five circulating microRNAs as potential biomarkers for prostate cancer

(2012) Zhang-Hui Chen et al.   PROSTATE

Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: A case control study

(2011) Wangyu Zhu et al.   BMC CANCER

Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells

(2011) Jing Chen et al.   GYNECOLOGIC ONCOLOGY

Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer

(2011) Niels H.H. Heegaard et al.   INTERNATIONAL JOURNAL OF CANCER

miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer

(2011) Kristen M. Foss et al.   Journal of Thoracic Oncology

Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis

(2011) Andreas Keller et al.   RNA Biology

miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death

(2010) L. Galluzzi et al.   CANCER RESEARCH

The miR-200 family controls  -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

(2010) S. Leskela et al.   ENDOCRINE-RELATED CANCER

Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer

(2010) Zhibin Hu et al.   JOURNAL OF CLINICAL ONCOLOGY

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)

(2010) Evan M. Kroh et al.   METHODS

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer

(2009) M. Raponi et al.   CANCER RESEARCH

MicroRNAs and Cancer: Short RNAs Go a Long Way

(2009) Andrea Ventura et al.   CELL

Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer

(2009) Zhaohui Huang et al.   INTERNATIONAL JOURNAL OF CANCER

MicroRNA Signature Predicts Survival and Relapse in Lung Cancer

(2008) Sung-Liang Yu et al.   CANCER CELL

A Double-Negative Feedback Loop between ZEB1-SIP1 and the microRNA-200 Family Regulates Epithelial-Mesenchymal Transition

(2008) C. P. Bracken et al.   CANCER RESEARCH

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

(2008) Xi Chen et al.   CELL RESEARCH

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

(2008) S.-M. Park et al.   GENES & DEVELOPMENT

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

(2008) Philip A. Gregory et al.   NATURE CELL BIOLOGY

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

(2008) Johan Skog et al.   NATURE CELL BIOLOGY

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA